1. Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential
   Dharambir Kashyap et al, 2018, Mol Diagn Ther CrossRef
2. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
   Srinivas V. Koduru et al, 2018, Sci Rep CrossRef
3. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
   Lin Zhu et al, 2018, CBM CrossRef
4. Genetic and Epigenetic Pathways of lethal (2) giant larvae Tumor Suppressor in Drosophila melanogaster
   N. Ya. Weisman, 2019, Russ J Genet CrossRef
5. Non-coding RNAs as potential therapeutic targets in breast cancer
   Deepti Tomar et al, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
6. NOTCH Signaling Pathway and Non-coding RNAs in Cancer
   Jing Guo et al, 2019, Pathology - Research and Practice CrossRef
7. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics
   Chun-yao Li et al, 2017, Med Sci Monit CrossRef
8. The Regulatory Role of MicroRNAs in Breast Cancer
   Hui-Yi Loh et al, 2019, IJMS CrossRef
9. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis
   Wen-Yu Hu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
10. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
    Maryam Abolghasemi et al, 2019, J Cell Physiol CrossRef
11. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG
    Ning An et al, 2020, Technol Cancer Res Treat CrossRef
12. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
    Yingyu Ma et al, 2017, Oncotarget CrossRef
13. Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography
    Julia Alejandra Pezuk et al, 2017, Oncotarget CrossRef
14. Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a
    Sweta Sikder et al, 2019, Oncotarget CrossRef
15. MicroRNA‑4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells
    Li Jing et al, 2019, Mol Med Report CrossRef
16. Role of microRNA in forming breast carcinoma
    Momi Saikia et al, 2020, Life Sciences CrossRef
17. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
    Ishita Gupta et al, 2020, IJMS CrossRef
18. GPER1 and microRNA: Two Players in Breast Cancer Progression
    Adele Vivacqua, 2020, IJMS CrossRef
19. The role of tumor suppressor short non-coding RNAs on breast cancer
    Shokooh Salimimoghadam et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
20. Is the regulation by miRNAs of NTPDase1 and ecto-5’-nucleotidase genes involved with the different profiles of breast cancer subtypes?
    Fernanda Cardoso da Silva et al, 2021, Purinergic Signalling CrossRef
21. miRNA-101 Targets TGF-βR1 to Retard the Progression of Oral Squamous Cell Carcinoma
    Yong Wang et al, 2020, oncol res CrossRef
22. Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
    Xiaochen Yang et al, 2021, IJGM CrossRef
23. miR-622 Induces Breast Cancer Cell MCF-7 Proliferation, Migration, and Invasion by Directly Negatively Targeting EYA1
    Pan Tang et al, 2022, Journal of Nanomaterials CrossRef
24. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
    Deniz Mortazavi et al, 2022, Journal of Oncology CrossRef
25. Maternal Nutrition During Gestation Alters Histochemical Properties, and mRNA and microRNA Expression in Adipose Tissue of Wagyu Fetuses
    Yi Zhang et al, 2022, Front. Endocrinol. CrossRef
26. miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
    Lisa Svartdal Normann et al, 2022, BCTT CrossRef
27. Significance of Cyclooxgenase-2 gene polymorphism and related miRNAs in pulmonary arterial hypertension
    Sinem Durmus et al, 2022, Clinical Biochemistry CrossRef
28. The role of epigenetic modifications in drug resistance and treatment of breast cancer
    Mohsen Karami Fath et al, 2022, Cell Mol Biol Lett CrossRef
29. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
    Ahmed Ismail et al, 2022, International Journal of Biological Macromolecules CrossRef
30. MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem
    Ning Liu et al, 2022, Cancers CrossRef
31. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition
    Qingyi Hu et al, 2023, IJMS CrossRef
32. Stem cell division and its critical role in mammary gland development and tumorigenesis: current progress and remaining challenges
    Peng Zeng et al, 2024, Stem Cells and Development CrossRef
33. Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells
    Cynthia Aslan et al, 2024, Clinical Nutrition ESPEN CrossRef
34. EYA3 promotes the tumorigenesis of gastric cancer through activation of the mTORC1 signaling pathway and inhibition of autophagy
    Zhen Xu et al, 2024, Sci Rep CrossRef